Sam Altman has reportedly floated giving the US government a 5% stake in OpenAI, an arrangement that could be worth $42.6 billion and may pull rivals like Anthropic and Google into a similar bargain.

A 927-page ethics filing has confirmed what crypto Twitter already suspected, Trump’s crypto income didn’t just grow last year, it exploded, outpacing every publicly traded digital-asset company in America.

Record M&A deals have turned boardrooms into arenas of one-upmanship, with global dealmaking on track to hit $5.3 trillion this year, the second-biggest haul ever.

A relentless heat dome turned June 2026 into Europe’s hottest month on record, killing more than 1,300 people and forcing red alerts from Lisbon to Warsaw.

Australia has lost its long-held “bird flu-free” status as H5N1 is now confirmed in both Western Australia and South Australia, with poultry exports blocked, a third suspect case emerging, and iconic native wildlife facing an existential threat.

CRED founder Kunal Shah is leaving India’s most premium credit card club to run the world’s biggest messaging app. Meta just paid $900 million for the privilege of making that happen, and nobody’s arguing it wasn’t a calculated move.

Anthropic spent years asking governments to regulate AI. The Trump administration finally obliged, with an export ban, a Pentagon blacklist, and exactly 90 minutes’ warning. Careful what you wish for.

India as a Global Growth Engine is rewriting the script of the world economy in 2026, while many advanced nations struggle with sluggish growth.

French beauty behemoth L’Oréal has signed an agreement to acquire a majority stake in Innovist, the Gurugram-based D2C startup behind Bare Anatomy and Chemist at Play, in what could be the biggest deal in India’s digital-first beauty landscape.

Noam Shazeer joins OpenAI, leaving Google just 18 months after a $2.7 billion deal brought him back. The Gemini co-lead and transformer co-inventor’s move is the biggest AI talent heist of 2026.

SpaceX market value surpasses Amazon just four days after its historic $135-per-share IPO on Nasdaq, as shares soared over 55%, valuing Elon Musk’s rocket empire at nearly $2.8 trillion and making him the world’s first trillionaire.

WIPO ranks Jio Platforms in the global top 20 of PCT patent applicants for 2025, with a jaw-dropping 320-place jump. The Reliance-backed tech giant now stands alongside Huawei, Apple, and Google, and yes, it’s the only Indian name on that list.

Elon Musk is on the verge of becoming the world’s first trillionaire as SpaceX lists on Nasdaq at a staggering $1.77 trillion valuation, a number so absurd it almost sounds like a typo.

The Pentagon has officially redesignated Alibaba, BYD, Baidu, and over a dozen other major Chinese firms as “Chinese military companies”, a blacklist that keeps growing even as Washington and Beijing sip tea together.

Ukrainian President Volodymyr Zelenskyy sent an open letter to Vladimir Putin on June 4, proposing a face-to-face meeting in a neutral country and a full ceasefire during negotiations, after over four years of war and more than 1.37 million Russian casualties.

The Del Vecchio inheritance dispute, a four-year soap opera played out in courtrooms from Milan to Luxembourg over the fortune behind EssilorLuxottica, has taken a significant turn, with two of the billionaire heirs reaching a provisional agreement to stand down from legal warfare.

The USTR has proposed 12.5% additional duties on India and 53 other countries for allegedly failing to ban goods made with forced labour and the timing couldn’t be more awkward, with US trade delegates literally in New Delhi as the report dropped.

SoftBank overtakes Toyota as Japan’s most valuable listed company after an AI-driven 14% single-day surge pushed its market cap above ¥48 trillion, ending Toyota’s 22-year reign at the top of Japan’s corporate pile.

Wockhardt’s Zaynich FDA approval has made history as the first New Chemical Entity fully developed by an Indian pharma company to receive a US FDA nod. With an 89% efficacy rate against drug-resistant Gram-negative bacteria and eyes on a $9 billion antibiotics market, India’s pharma ambitions just got a whole lot louder.

India has officially confirmed a BrahMos missile deal with Vietnam, while the BrahMos missile Indonesia deal is reportedly in its final stages, making Southeast Asia the newest fan club of the world’s fastest supersonic cruise missile. Here’s why everyone wants a piece of it.